Giulia Ferrannini (Anna Norhammar)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

Diabetes care

European heart journal. Cardiovascular pharmacotherapy

BMJ open

Scandinavian cardiovascular journal : SCJ

Karolinska Institutet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Institutet

Sweden

PhD fellow :: Medicine

Karolinska Institutet Mar 19 2018 - Jan 01 2020

Sweden

Research Fellow :: Medicine

Università degli Studi di Torino Dec 10 2014 - Dec 10 2019

Italy

Internal Medicine Resident :: Scienze Mediche

Columbia University Mar 01 2014 - Jun 01 2014

United States

Research Fellow :: Columbia University Diabetes and Endocrinology Research Center

Publications

Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, Javed Butler, Marco Metra, Lars H Lund, Giulia Ferrannini, Gianluigi Savarese
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries. European heart journal. Cardiovascular pharmacotherapy (2024)
Aurora Merolla, Rebecca De Lorenzo, Giulia Ferrannini, Cristina Renzi, Francesca Ulivi, Elena Bazzigaluppi, Vito Lampasona, Emanuele Bosi
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol. BMJ open 14 (3) (2024)
Aurora Merolla, Rebecca De Lorenzo, Giulia Ferrannini, Cristina Renzi, Francesca Ulivi, Elena Bazzigaluppi, Vito Lampasona, Emanuele Bosi
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol. BMJ open 14 (3) (2024)
Aurora Merolla, Rebecca De Lorenzo, Giulia Ferrannini, Cristina Renzi, Francesca Ulivi, Elena Bazzigaluppi, Vito Lampasona, Emanuele Bosi
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol. BMJ open 14 (3) (2024)
Giulia Ferrannini, Juan M Maldonado, Sohini Raha, Purnima Rao-Melacini, Rutaba Khatun, Charles Atisso, Linda Shurzinske, Hertzel C Gerstein, Lars Rydén, M Angelyn Bethel
Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial. Scandinavian cardiovascular journal : SCJ 57 (1) (2023)
Giulia Ferrannini, Juan M Maldonado, Sohini Raha, Purnima Rao-Melacini, Rutaba Khatun, Charles Atisso, Linda Shurzinske, Hertzel C Gerstein, Lars Rydén, M Angelyn Bethel
Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial. Scandinavian cardiovascular journal : SCJ 57 (1) (2023)
Elena Fortin, Beatrice Campi, Eleuterio Ferrannini, Andrea Mari, Linda G Mellbin, Anna Norhammar, Per Näsman, Lars Ryden, Alessandro Saba, Giulia Ferrannini
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors. Diabetes care (2023)
Giulia Ferrannini, Dirk De Bacquer, Iris Erlund, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Oliver Schnell, Jaakko Tuomilehto, Terhi Vihervaara, David Wood, Lars Rydén
Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population. Diabetes care 45 (9) (2022)
Giulia Ferrannini, Francesco Cosentino
SGLT2i: new perspectives in diabetes and kidney disease. European heart journal. Cardiovascular pharmacotherapy 7 (3) (2022)
Giulia Ferrannini, Lars H Lund, Lina Benson, Manfredi Rizzo, Wael Almahmeed, Giuseppe M C Rosano, Gianluigi Savarese, Francesco Cosentino
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis. European heart journal. Cardiovascular pharmacotherapy (2022)
Giulia Ferrannini, Linda G Mellbin, Faith Kirabo, Chinthanie Ramasundarahettige, Hertzel C Gerstein, Lars Rydén
Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis. Diabetes care 45 (10) (2022)
Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, Guy De Backer, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Jaakko Tuomilehto, David Wood, Lars Rydén, null null
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys. Cardiovascular diabetology 20 (1) (2021)
Giulia Ferrannini, Ulagamadesan Venkatesan, Helen Martina Colhoun, Gilles R Dagenais, Rafael Diaz, Leanne Dyal, Mark Lakshmanan, Linda Mellbin, Jeffrey L Probstfield, Matthew Casey Riddle, Jonathan Edward Shaw, Alvaro Avezum, Jan Neil Basile, William C Cushman, Petr Jansky, Mátyás Keltai, Fernando Tomás Lanas Zanetti, Lawrence Alan Leiter, Patricio López-Jaramillo, Prem Pais, Valdis Pīrāgs, Nana Pogosova, Peter Johann Raubenheimer, Wayne Huey-Herng Sheu, Lars Rydén
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin. European heart journal 42 (26) (2021)
Giulia Ferrannini, Dirk De Bacquer, Guy De Backer, Kornelia Kotseva, Linda Mellbin, David Wood, Lars Ryden, null null
Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V. Diabetes care 43 (4) (2020)
Giulia Ferrannini, Giulia Ferrannini, Viveca Gyberg, Linda Mellbin, Lars Ryden
Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management. Diabetes care 43 (9) (2020)
Giulia Ferrannini, Elisabet Svenungsson, Barbro Kjellström, Kerstin Elvin, Giorgia Grosso, Per Näsman, Lars Rydén, Anna Norhammar
Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor? Diabetes & vascular disease research 17 (3) (2020)
Giulia Ferrannini, Maria Laura Manca, Marco Magnoni, Felicita Andreotti, Daniele Andreini, Roberto Latini, Attilio Maseri, Aldo P Maggioni, Rachel M Ostroff, Stephen A Williams, Eleuterio Ferrannini
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes care 43 (4) (2020)

Giulia Ferrannini.css-eqlu8i{font-size:small;padding-left:4px;} (Anna Norhammar)

Publication Activity (10 Years)

Top Topics

Top Venues

Giulia Ferrannini (Anna Norhammar)